Drug Shortage Report for VENTOLIN HFA
Report ID | 208287 |
Drug Identification Number | 02241497 |
Brand name | VENTOLIN HFA |
Common or Proper name | salbutamol pressurised inhalation, suspension |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | SALBUTAMOL |
Strength(s) | 100MCG |
Dosage form(s) | METERED-DOSE AEROSOL |
Route of administration | INHALATION INHALATION |
Packaging size | 1x200 |
ATC code | R03AC |
ATC description | ADRENERGICS, INHALANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-10-26 |
Estimated end date | 2024-02-01 |
Actual end date | 2024-02-01 |
Shortage status | Resolved |
Updated date | 2024-02-02 |
Company comments | Inventory on allocation to support demand. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2024-02-02 | French | Compare |
v12 | 2024-02-02 | English | Compare |
v11 | 2023-12-06 | French | Compare |
v10 | 2023-12-06 | English | Compare |
v9 | 2023-11-29 | French | Compare |
v8 | 2023-11-29 | English | Compare |
v7 | 2023-11-22 | French | Compare |
v6 | 2023-11-22 | English | Compare |
v5 | 2023-11-08 | French | Compare |
v4 | 2023-11-08 | English | Compare |
v3 | 2023-10-27 | English | Compare |
v2 | 2023-10-26 | French | Compare |
v1 | 2023-10-26 | English | Compare |
Showing 1 to 13 of 13